Maximizing the potency of an anti-TLR4 monoclonal antibody by exploiting proximity to Fcγ receptors: Fc-mediated avidity enhances the potency of an anti-TLR4 antibody

In order to treat Toll like receptor 4 (TLR4)-mediated diseases, we generated a potent antagonistic antibody directed against human TLR4, Hu 15C1. This antibody's potency can be modulated by engaging not only TLR4 but also Fcγ receptors (FcγR), a mechanism that is driven by avidity and not cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Loyau, Jérémy, Malinge, Pauline, Daubeuf, Bruno, Shang, Limin, Elson, Greg, Kosco-Vilbois, Marie, Fischer, Nicolas, Rousseau, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2014
Materias:
Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622919/
https://www.ncbi.nlm.nih.gov/pubmed/25484053
http://dx.doi.org/10.4161/19420862.2014.975098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622919/
https://www.ncbi.nlm.nih.gov/pubmed/25484053
http://dx.doi.org/10.4161/19420862.2014.975098

Ejemplares similares